§7612a HIV/AIDS Working Capital Fund

Summary

Creates an HIV/AIDS Working Capital Fund so the U.S. coordinator for global HIV/AIDS work can keep a safe, secure, and steady supply of drugs and other items needed to treat people with HIV/AIDS and related infections. Coordinator: the U.S. official in charge of global HIV/AIDS activities. HIV/AIDS Fund: the new working capital account. Money in the Fund can be used without a time limit for six types of needs, including anti‑retroviral drugs, other medicines and medical items, lab and test supplies, clinic and prevention supplies (like for preventing mother‑to‑child transmission), palliative care commodities, and equipment for labs, clinics, transport, and storage. Federal agencies and other sources may pay into the Fund during any fiscal year at actual cost, actual cost plus extra costs, or any price the Coordinator agrees to. Payments for loss or damage to Fund supplies, rebates, refunds, reimbursements, and other credits may also go into the Fund. At the end of each fiscal year the Coordinator may move any amounts the Coordinator finds are more than the Fund needs into other HIV/AIDS programs, and must send the Appropriations Committees a report on the Fund’s finances, income sources, and spending.